Wednesday, July 8, 2026

biotech · Recurrent Head and Neck Cancer · Metastatic Head and Neck Cancer · PDSB

PDS Biotechnology

PDS Biotechnology clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Princeton, USA HQ
2005 Founded
32 Employees
Public company Type
PDSB · NYSE Ticker
Company details
Status
Public
HQ
Princeton, USA
Founded
2005
Employees
32
Programs
3
Drugs
5
Patents
11
Intelligence · Clinical Programs

PDS Biotechnology projects

1 ClinicalTrials.gov programs sponsored by PDS Biotechnology.

PDS Biotechnology has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Pembrolizumab (KEYTRUDA®) and PDS0101

    PDS Biotechnology Corp

    Metastatic Head and Neck Cancer

    phase 2 other completed

    1 trial

Frequently asked questions

How many clinical projects does PDS Biotechnology have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.